T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$1.15B |
| 2 |
Apple
AAPL
|
+$742M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$647M |
| 4 |
Flowserve
FLS
|
+$577M |
| 5 |
Visa
V
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NWSA
NEWS CORPORATION CL-A
NWSA
|
+$909M |
| 2 |
Union Pacific
UNP
|
+$741M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$580M |
| 4 |
Edwards Lifesciences
EW
|
+$531M |
| 5 |
Accenture
ACN
|
+$474M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.66% |
| 2 | Consumer Discretionary | 13.63% |
| 3 | Financials | 13.54% |
| 4 | Industrials | 11.61% |
| 5 | Technology | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Zoetis
ZTS
$31.3B
| $199M | 0.05% |
6,405,406
+3,452,513
| +117% | +$106M |
|
|
MDCO
402
DELISTED
Medicines Co
MDCO
| $198M | 0.05% |
5,918,325
+166,230
| +3% | +$5.3M |
|
403
RH
RH
$3.4B
| $198M | 0.05% |
3,130,700
+1,338,900
| +75% | +$92.4M |
|
|
BHI
404
DELISTED
Baker Hughes
BHI
| $198M | 0.05% |
4,032,879
-1,065,708
| -21% | -$51.4M |
|
405
Microchip Technology
MCHP
$42.2B
| $198M | 0.05% |
9,811,738
-59,000
| -0.6% | -$1.17M |
|
406
Five Below
FIVE
$13.4B
| $198M | 0.05% |
4,516,350
+43,700
| +1% | +$1.75M |
|
|
PRA
407
DELISTED
ProAssurance
PRA
| $197M | 0.05% |
4,380,778
-32,200
| -0.7% | -$1.61M |
|
408
Affiliated Managers Group
AMG
$9.7B
| $197M | 0.05% |
1,077,979
+136,000
| +14% | +$24.2M |
|
409
Crown Holdings
CCK
$12.9B
| $196M | 0.05% |
4,636,770
+116,209
| +3% | +$5.08M |
|
410
Enpro
NPO
$7.12B
| $196M | 0.05% |
3,251,258
+129,100
| +4% | +$7.48M |
|
411
SLM Corp
SLM
$5.22B
| $195M | 0.05% |
21,948,430
-26,833,211
| -55% | -$234M |
|
412
Packaging Corp of America
PKG
$22.9B
| $195M | 0.05% |
3,420,055
+83,500
| +3% | +$4.52M |
|
|
LIFE
413
DELISTED
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
| $195M | 0.05% |
2,609,051
+32,000
| +1% | +$2.39M |
|
414
Sysco
SYY
$40B
| $195M | 0.05% |
6,123,670
-339,890
| -5% | -$11.4M |
|
415
CoStar Group
CSGP
$13.4B
| $194M | 0.05% |
11,583,710
+669,750
| +6% | +$10.3M |
|
416
Ball Corp
BALL
$16.4B
| $192M | 0.05% |
8,560,494
+2,435,580
| +40% | +$54.7M |
|
|
PPL
417
PPL Corp
PPL
$26.8B
| $190M | 0.05% |
6,724,650
+151,759
| +2% | +$4.35M |
|
|
BBG
418
DELISTED
Bill Barrett Corp
BBG
| $190M | 0.05% |
7,571,993
-24,413
| -0.3% | -$549K |
|
|
WCG
419
DELISTED
Wellcare Health Plans, Inc.
WCG
| $189M | 0.05% |
2,707,108
-15,300
| -0.6% | -$979K |
|
420
Sensata Technologies
ST
$6.61B
| $188M | 0.05% |
4,915,900
+1,300
| +0% | +$48.7K |
|
|
CMCSK
421
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
| $188M | 0.05% |
4,333,835
-182,900
| -4% | -$7.93M |
|
422
Texas Capital Bancshares
TCBI
$4.38B
| $187M | 0.05% |
4,073,050
+358,730
| +10% | +$16.5M |
|
423
Valmont Industries
VMI
$9.5B
| $185M | 0.05% |
1,332,084
-148,170
| -10% | -$21.2M |
|
424
Amdocs
DOX
$6.23B
| $185M | 0.05% |
5,037,000
-5,250,700
| -51% | -$198M |
|
425
Monro
MNRO
$352M
| $183M | 0.05% |
3,927,490
-134,975
| -3% | -$6.16M |
|
Similar funds
T. Rowe Price Associates's Q3 2013 Portfolio in Review
As of Q3 2013, T. Rowe Price Associates held 2,531 positions worth $400B, up 7% from $374B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q3 2013 filing shows 100 new, 822 increased, 1,027 reduced and 76 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 36,580,054 shares worth $1.23B. The largest sale was NEWS CORPORATION CL-A, an estimated $909M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 36,580,054 shares worth $1.23B.
- T. Rowe Price Associates added most to Apple in Q3 2013, an estimated $742M increase.
- T. Rowe Price Associates's biggest Q3 2013 reduction was Union Pacific, cutting an estimated $741M.
- T. Rowe Price Associates fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $909M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $400B portfolio in Q3 2013.
- T. Rowe Price Associates opened 100 new positions and closed 76 in Q3 2013.
- T. Rowe Price Associates's portfolio value rose 7% quarter-over-quarter to $400B.
Based on T. Rowe Price Associates's 13F filing for Q3 2013, filed 14 Nov 2013.